FDA orphan drug designation: treatment of retinitis pigmentosa
All entries for: BlueRock Therapeutics LP
December 10, 2025
BlueRock Therapeutics LP
Orphan Drug Designation
Disease Area: Rare Diseases
FDA orphan drug designation: treatment of retinitis pigmentosa